Disclosures for "Evaluating the Therapeutic Potential of Emerging Precision Sodium Channel Modulators in Pain"
-
Dr. Kahlig has received personal compensation for serving as an employee of Praxis Precisoin Medicines. Dr. Kahlig has stock in Praxis Precision Medicines.
-
Dr. Anderson has received personal compensation for serving as an employee of Praxis Precision Medicines.
-
Dr. Rietdijk has nothing to disclose.
-
Miss Claessens has nothing to disclose.
-
Prof. Groeneveld has nothing to disclose.
-
Marcio Souza has received personal compensation for serving as an employee of Praxis Precision Medicines.
-
Dr. Petrou has received personal compensation for serving as an employee of Praxis Precision Medicines. Dr. Petrou has stock in Praxis Precision Medicines. The institution of Dr. Petrou has received research support from Praxis Precision Medicines. Dr. Petrou has received intellectual property interests from a discovery or technology relating to health care.